Sanglifehrin derivatives and methods for their production
US9271977B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2011 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | May 24, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided inter alia compounds of formula (I) and (II)and their use in therapy, particularly for the treatment of viral infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.